Therapeutic Vulnerabilities in Acute Myeloid Leukemia (AML) with TP53 Alterations von Ogunsan, Oluwateniayo, Antony, Marie Lue, Noble-Orcutt, Klara E., He, Fiona, Sachs, Zohar

Volltext

Cell Type-Specific Effects of Crizotinib in Human Acute Myeloid Leukemia with TP53 Alterations von Antony, Marie Lue, Noble-Orcutt, Klara, Ogunsan, Oluwateniayo, He, Fiona, Sachs, Zohar

Volltext

JAK/STAT Inhibition Targets TP53 altered Primary Human Acute Myeloid Leukemia Stem Cells von Antony, Marie Lue, Noble-Orcutt, Klara, Lee, Yoonku, Ogunsan, Oluwateniayo, Jensen, Jeffrey Lee, He, Fiona, Sachs, Zohar

Volltext